Rock Springs Capital Management LP Biomarin Pharmaceutical Inc Transaction History
Rock Springs Capital Management LP
- $2.94 Billion
- Q3 2024
A detailed history of Rock Springs Capital Management LP transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Rock Springs Capital Management LP holds 151,000 shares of BMRN stock, worth $9.58 Million. This represents 0.36% of its overall portfolio holdings.
Number of Shares
151,000
Previous 151,000
-0.0%
Holding current value
$9.58 Million
Previous $12.4 Million
14.62%
% of portfolio
0.36%
Previous 0.39%
Shares
13 transactions
Others Institutions Holding BMRN
# of Institutions
635Shares Held
178MCall Options Held
2.01MPut Options Held
1.28M-
Black Rock Inc. New York, NY22.7MShares$1.44 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19.3MShares$1.22 Billion0.02% of portfolio
-
Primecap Management CO Pasadena, CA18.9MShares$1.2 Billion0.99% of portfolio
-
Dodge & Cox San Francisco, CA13.9MShares$881 Million0.59% of portfolio
-
Capital Research Global Investors Los Angeles, CA10.5MShares$666 Million0.16% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $11.8B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...